Merck & Co., Inc. (MRK) Stock Depends on Januvia More Than Ever
Merck & Co., Inc. (NYSE:MRK) stock has become dependent on its diabetes drug Januvia over the past couple of years for revenue growth.
Posts Tagged ‘Bristol Myers Squibb Co. (BMY)’
Who Really, Really Wants Some More Pfizer Inc. (PFE) Stock?
An entity with deep pockets is looking to buy boatloads of Pfizer Inc. (NYSE:PFE) stock. And we're talking yacht-sized boatloads -- not canoe-sized ones.
Idenix Pharmaceuticals Inc (IDIX), Bristol Myers Squibb Co. (BMY): The Most Unlucky Biotech in the World
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) just can't catch a break.
Eli Lilly & Co. (LLY), Bristol Myers Squibb Co. (BMY): Can’t Anyone Tackle Alzheimer’s?
After a series of failures, one is forced to wonder whether the medical fraternity, including the research and development wing of Eli Lilly & Co.
Is This What the Doctor Ordered for Eli Lilly & Co. (LLY)?
After the failure of its pipeline products for Alzheimer’s and rheumatoid arthritis, the drug giant Eli Lilly & Co. (NYSE:LLY) finally has some good news to report.
Buy Johnson & Johnson (JNJ)?
Stocks that stand the test of time are often ones that have a diversified product portfolio of world class brands.
Abbott Laboratories (ABT), AbbVie Inc (ABBV): This FDA Approval Is Exciting News for Hepatitis-C Patients
Hepatitis-C is a contagious virus that attacks the liver and can be found in acute or chronic forms.
Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY): The Diabetes Drug War
Technological advances have allowed for people to have more longevity. Drug companies research and develop medicines to prevent, control and cure diseases.
Gilead Sciences, Inc. (GILD), Bristol Myers Squibb Co. (BMY): The Best Healthcare Bet
Gilead Sciences, Inc. (NASDAQ:GILD) has been one of the most prolific investments in the healthcare sector.
Beware the Bullishness on Bristol Myers Squibb Co. (BMY)
A new drug in the fight against cancer is certainly an exciting and welcome development.
Bristol Myers Squibb Co (BMY), Momenta Pharmaceuticals, Inc. (MNTA): White Collar Criminals Love Biotech Stocks
It's understandably very tempting for people with inside information to trade biotech stocks.
Intuitive Surgical, Inc. (ISRG), MAKO Surgical Corp. (MAKO): This Is the Leading Cause of Preventable Hospital Patient Deaths
When we go to the hospital, the last thing on our mind is that something could go wrong or that we could actually become sicker than when we first went in.
ImmunoGen, Inc. (IMGN), Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): A Trio of Cancer Immunotherapy Innovators
The cancer world has been abuzz after an exciting ASCO conference. Bristol Myers Squibb Co.
Amgen, Inc. (AMGN), Bristol Myers Squibb Co. (BMY): Ovarian Cancer Drug Half Way There
The biotech giant announced today that its cancer drug trebananib combined with chemotherapy paclitaxel extended median progression-free survival in recurrent ovarian cancer patients...
Why The Pfizer Inc. (PFE)-Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Settlement Affects the Whole Industy
Generic-drug makers are always on the hunt for the next branded drug to take down.
Is Pfizer Inc. (PFE) a Buy?
The biggest pharmaceutical companies in the United States are in an enviable position. They sell products that are literally a matter of life and death.
Dendreon Corporation (DNDN), Celldex Therapeutics, Inc. (CLDX): A Promising Platform for Cancer Immunotherapy
A 2011 Nobel Prize in Physiology and Medicine is certainly impressive. Using a novel cancer treatment on yourself is both impressive and courageous. Dr.
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Why You Should Care About This Diabetes Drug Saga
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s diabetes drug Avandia causes heart issues. Or maybe it doesn't.
Should You Buy AstraZeneca plc (ADR) (AZN)?
Is AstraZeneca plc (ADR) (NYSE:AZN) a healthy stock for your portfolio? Investors who are in the know are getting more bullish.
Google Inc (GOOG), Eli Lilly & Co. (LLY) and More: Billionaire Jim Simons’ Buy Ups
Billionaire Jim Simons founded Renaissance Technologies ("RenTech"), his private investment firm, in 1982.
Revlimid Gains, Celgene Corporation (CELG) Loses
Celgene Corporation (NASDAQ:CELG) announced good news today about its blockbuster drug Revlimid. Did the stock jump as a result? Nope. Shares actually fell by more than 4%.
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS), Regulus Therapeutics Inc (RGLS): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Intel Corporation (INTC), Bristol Myers Squibb Co. (BMY): Three Noteworthy Upgrades Worth a Look
Intel Corporation (NASDAQ:INTC) traded higher after last weekend’s feature story in Barron’s.
Bristol Myers Squibb Co. (BMY): This Pharma Is Trading Like a Biotech
This chart is just unbelievable.
Merck & Co., Inc. (MRK), Bristol Myers Squibb Co. (BMY): Breakthrough Melanoma Data Drives Pharmas Higher
Yesterday, Merck & Co., Inc. (NYSE:MRK) reported overwhelmingly positive interim results for its experimental melanoma drug lambrolizumab.
AstraZeneca plc (ADR) (AZN): This Pharma Company Is Making the Right Moves
Mergers and acquisitions appear to be continuously reshaping the pharmaceuticals industry.
Bristol Myers Squibb Co. (BMY), Ariad Pharmaceuticals, Inc. (ARIA): ASCO Investment Ideas
The American Society of Clinical Oncology annual meeting kicks off today.
Hedge Funds Are Selling GlaxoSmithKline plc (ADR) (GSK)
If you'd ask most stock holders, hedge funds are assumed to be underperforming, outdated financial vehicles of yesteryear.
AbbVie Inc (ABBV): Hedge Funds and Insiders Are Bullish, What Should You Do?
According to most market participants, hedge funds are assumed to be underperforming, old financial vehicles of yesteryear.
Three Things About to Move Johnson & Johnson (JNJ) Stock
Johnson & Johnson (NYSE:JNJ) may be involved in everything from hip implants to pharmaceuticals, but it's the latter that brings in the majority of the profits and fuels any...
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): This Obesity Drugmaker Is Badly In Need of a Marketing Partner
As recently as a decade ago, the biggest hurdle for biotech companies wasn't competition from their peers or even the sale price of their drugs.
Bristol Myers Squibb Co. (BMY), Gilead Sciences, Inc. (GILD), Halozyme Therapeutics, Inc. (HALO): 3 Stocks to Watch Ahead of ASCO
At the annual ASCO meeting in Chicago, thousands of health-care researchers and professionals unite to advance cancer treatment.
Dendreon Corporation (DNDN), Bristol Myers Squibb Co. (BMY): Why Immunotherapy Stocks Could Be Set for a Big Move
If the JPMorgan Healthcare Conference in January is the mecca of all health-care events during the year, then the American Society of Clinical Oncology's annual meeting in Chicago...
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): The Top Three Causes of Diabetes
A whopping 25.3 million people in the U.S. right now are diabetic, with an additional 79 million Americans in the pre-diabetes stage.
This Metric Says You Are Smart to Sell Bristol Myers Squibb Co. (BMY)
Bristol Myers Squibb Co. (NYSE:BMY) was in 33 hedge funds' portfolio at the end of the first quarter of 2013.
Amgen, Inc. (AMGN), Bristol Myers Squibb Co. (BMY): Can Financial Innovation Unlock a Cure for Cancer?
A few years ago, Andrew W. Lo from the MIT Sloan School of Management gave a lengthy talk at a meet-and-greet for prospective students of the Master of Finance program.
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN): The Top Three Diseases Caused by Stress
Let's face it; we all dislike stress, but it's something we all live with to some degree.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) – Pick Your Poison: Overweight or High Cholesterol
Overweight and have high cholesterol? You may have to pick one to work on at a time, according to data from the lab of John Thyfault, an associate professor of nutrition and exercise...
Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against Leukemia
As I noted 11 weeks ago, cancer statistics are both staggering and disappointing.
MannKind Corporation (MNKD): Why Have Shares Moved?
MannKind Corporation (NASDAQ:MNKD) took one giant leap over the past few days.
Roche Holding Ltd. (ADR) (RHHBY), Bristol Myers Squibb Co. (BMY): Cancer Meeting Highlights the Good and Bad of the Immune System
Biotech investors rejoice. The ASCO abstracts are here.
Verizon Communications Inc. (VZ), General Mills, Inc. (GIS) & 4 Must-Own Stocks
As the chatter surrounding a market pullback continues to build, these companies remain good investments. We look at fours stocks in four different sectors that meet the below...
And The Best Bargain Is…Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY) or Pfizer Inc. (PFE)?
Many stocks within the pharmaceutical industry have rallied significantly over the past few years and now sit at multi-year highs.
Busy Day For Bristol Myers Squibb Co. (BMY) Options As Shares Sprint Higher
Bristol Myers Squibb Co. (NYSE:BMY) – Shares in drug maker, Bristol Myers Squibb Co.
Is Gilead Sciences, Inc. (GILD) Still A Buy?
Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2.
Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) & What To Watch
Pharmaceutical companies in the U.S. are not having it easy these days.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Buying the Pharma Dips
Pfizer Inc. (NYSE:PFE) saw a strong pullback earlier this month, with its stock tumbling over 6% after reporting first-quarter earnings results.
Onyx Pharmaceuticals, Inc. (ONXX), Pfizer Inc. (PFE), And Kidney Cancer’s Top Bets
As I noted nine weeks ago, cancer statistics are both staggering and disappointing.
Bristol Myers Squibb Co. (NBMY), Eli Lilly & Co. (LLY), Johnson & Johnson (JNJ): Six Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part I
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
